ANAB
AnaptysBio Inc
48.50$
-0.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -7.2% | -10.3% | +5.3% | +15.5% | -1.9% | -12.8% | -20.6% | +5.3% | +3.2% | -9.5% | -3.9% | |
| – | -4.9% | -8.5% | -1.4% | +22.1% | -3.7% | -15.9% | -19.6% | +13.3% | +5.9% | -9.7% | -37.2% | |
| – | +36.8% | +49.3% | +33.8% | +166.7% | -35.8% | -19.9% | -55.1% | +147.9% | +116.9% | +4.3% | -46.1% | |
| – | -5.4% | -9.3% | -1.1% | +22.6% | -10.4% | -11.8% | -21.8% | -6.3% | +25.2% | -8.1% | -42.7% | |
| – | +109.6% | +3.5% | +27.1% | +35.4% | +234.3% | -56.1% | +19.8% | +253.4% | -55.3% | -23.9% | +22.9% | |
| – | +0.0% | +0.0% | +0.0% | -1,219,500,100.0% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.7% | -1.7% | +16.6% | -2.0% | +1.0% | -6.0% | -2.1% | +0.7% | -14.5% | -3.1% | -3.3% | |
| – | -4.4% | -13.7% | +25.1% | +8.6% | +3.5% | -3.1% | -19.3% | +7.3% | +1.4% | +8.0% | -15.2% | |
| – | +2.1% | +2.0% | +2.0% | +2.0% | +2.0% | +1.9% | +2.0% | +1.9% | +2.0% | +1.9% | +1.9% | |
| – | -28.0% | -2.5% | +6.7% | -26.5% | +11.4% | +53.0% | -45.6% | -13.1% | +33.8% | +94.2% | -41.5% | |
| – | -26.8% | -45.8% | -79.3% | +754.0% | -16.0% | -52.0% | -231.5% | – | – | -65.7% | -17.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.2% | +0.8% | +2.1% | +5.6% | +5.4% | +0.6% | -6.0% | +0.7% | +8.0% | -8.5% | +25.4% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.